FDA Approves Pfizer’s COVID-19 Booster for Teenagers of 16 and 17 Years Old

FDA Approves Pfizer’s COVID-19 Booster for Teenagers of 16 and 17 Years Old

Plenty of medical researchers are confident that giving the third COVID vaccine dose for a person is a good idea, which is also known as the booster dose. But some of them were hesitant when it came to injecting teenagers with the third jab.

According to The Washington Post, the Food and Drug Administration (FDA) approved the implementation of the COVID vaccine boosters for those young people of 16 and 17 years old. The decision is expected to bolster protection against both the Delta and Omicron variants of the coronavirus.

Three COVID vaccine doses should be enough to tackle Omicron

There are plenty of public voices out there rooting for the third dose of the coronavirus vaccine for some groups of people. An article from CNN posted in mid-November even claims that the definition for “fully vaccinated for COVID” is changing to three vaccine doses.

The new Omicron variant has recently emerged in the world, and it was first detected in South Africa. Scientists immediately started to wonder how dangerous it is and if vaccines work against it.

CBS News presents the FDA’s authorization below:

Alex Sigal is the leader of a recent study that firstly assessed how vaccinated people could behave in the face of the Omicron variant. He is confident that those who have chosen to get vaccinated for the coronavirus with the booster dose will be protected enough even in the case of severe illness caused by the Omicron variant.

Octavio Ramilo is chief of infectious diseases at a hospital in Columbus (Ohio), and he seemed happy about the authorization of the boosters for teenagers of 16 and 17 years of age, as quoted by The Washington Post:

These are the kids who go out, they have very active social lives,

So it’s very important that we protect them and the community.

Feel free to tell us what you think in a comment below!

 

Share this post

Post Comment